Stockreport

Epizyme's shares fall after receiving new FDA approval for cancer drug [MarketWatch]

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com
PDF Shares of Epizyme Inc. were down 2.3% in premarket trading on Friday, the day after it said the Food and Drug Administration had approved Tazverik as a treatment for rel [Read more]